Biossil
Biotech firm that uses AI to acquire and advance failed drug development projects.
Biossil is a biotech & life sciences company based in Toronto, CA. It has raised $153 million in disclosed funding. Its latest round was an Undisclosed stage of $153 million in September 2026.
Overview
No overview yet. It is written from sources once there are enough of them.
Funding
Total disclosed: $153M across 1 round. Computed only from sourced rounds.
Investors
Questions and answers
What does Biossil do?
Biotech firm that uses AI to acquire and advance failed drug development projects.
How much has Biossil raised?
Biossil has raised $153 million in disclosed funding across 1 round tracked by OSH.
Who has invested in Biossil?
Investors in Biossil include OpenAI Startup Fund, Founders Fund, Quiet Capital, Modern Capital, Golden Ventures and 3 more.
When and where was Biossil founded?
Biossil and is based in Toronto, CA.
Sources
- 1.Biossil hits unicorn status with new OpenAI-led financing — BetaKit, Sep 28, 2026